Physician

Gerardo Colon-Otero, MD

According to 2025 Medicare claims, Gerardo Colon-Otero, MD (NPI: 1598754228) practices hematology/oncology in the Jacksonville, FL market, with the plurality of this provider's patient population coming from Duval, FL. This provider's primary affiliated billing organization is MAYO CLINIC JACKSONVILLE (NPI: 1790772317; TIN: 593337028) and primary practice location at 32224-1865. Colon-Otero is affiliated with the St Vincents Accountable Care Organization LLC (ACO ID: A2205) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Colon-Otero's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 994 traditional Medicare patients, billed 136,498 HCPCS/CPT codes, and received $2,665,143 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 739 prescription claims across 126 beneficiaries totaling $583,172 in drug costs, led by Lynparza (Olaparib). 2023 DME data shows 96 claims. Open Payments data shows 29 records totaling $361,034. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $909,491 to $2,665,143. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	540	61,328	$909,491
2016	382	104,056	$1,073,335
2017	625	114,282	$1,525,392
2018	858	92,811	$1,704,332
2019	991	139,914	$2,007,635
2020	764	83,743	$1,502,966
2021	870	129,767	$2,362,029
2022	877	136,108	$2,498,097
2023	846	114,552	$2,182,332
2024	994	136,498	$2,665,143

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	174	939	$334,053
2016	188	936	$559,271
2017	187	974	$1,137,863
2018	176	846	$1,065,098
2019	158	710	$1,545,343
2020	134	763	$1,595,705
2021	145	895	$1,496,879
2022	136	739	$1,268,505
2023	110	570	$919,132
2024	126	739	$583,172

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	104	$62,508
2016	N/R	52	$23,981
2017	N/R	46	$10,312
2018	N/R	25	$3,688
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	24	$621
2023	N/R	96	$66,734
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	283	369	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	247	557	$92
36591	Collection of blood sample from implanted device	188	243	$19
96375	Injection of additional new drug or substance into vein	211	656	$12
J1100	Injection, dexamethasone sodium phosphate, 1 mg	146	2,056	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lynparza	Olaparib	13	390	$163,472
Eliquis	Apixaban	75	2,724	$51,770
Letrozole	Letrozole	57	3,720	$1,092
Prednisolone Acetate	Prednisolone Acetate	18	224	$718
Oxycodone Hcl	Oxycodone Hcl	23	603	$443

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$65	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	28	$360,969	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gerardo Colon-Otero, MD?

Tedicare shows public-source Medicare data for Gerardo Colon-Otero, MD (NPI 1598754228), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gerardo Colon-Otero, MD have ACO affiliation data?

Gerardo Colon-Otero, MD is shown with ACO affiliation data for St Vincents Accountable Care Organization LLC (MSSP, ACO ID A2205) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Gerardo Colon-Otero, MD?

Gerardo Colon-Otero, MD is linked to MAYO CLINIC JACKSONVILLE (billing NPI 1790772317) in the available physician profile data.

Does Gerardo Colon-Otero, MD have Open Payments data?

Gerardo Colon-Otero, MD has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.